Archived App (Last seen on 30 Jul 2026)
This is an archived listing of the app previously available on the App Store.
This application helps estimate the maximum safe starting dose for new therapeutics in adult clinical trials. It serves as an informational tool for healthcare providers, aiding in initial dosage calculations for healthy volunteers.
2.1
November 13, 2018
Removed CRO list for further development.
INDdose is used to estimate the maximum safe starting dose for new therapeutics in initial clinical trials involving adult healthy volunteers. It is intended for informational and educational purposes for healthcare providers.
No, INDdose is not intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in humans or animals. Healthcare providers should use their independent clinical judgment when incorporating its estimations into patient care.
INDdose is available for iPhone, iPad, and iPod devices, indicating compatibility with Apple's iOS ecosystem.
The latest version of INDdose is 2.1, which was last updated on November 13, 2018. Users can expect updates to maintain functionality and potentially add new features over time.
INDdose has an age rating of 12+, suggesting it is suitable for users aged 12 and older.
INDdose has received a positive rating of 4.4 stars based on 7 user reviews, indicating general satisfaction among its users.
No, INDdose does not contain advertisements, as indicated by the 'hasAds' flag being false.
Yes, INDdose is available for free, meaning there are no upfront costs or purchase required to download and use the application.
